Imperial Capital Reiterates In-Line on Stericycle Inc (SRCL) Following 4Q Earnings
Imperial Capital maintained an In-Line rating on Stericycle (NASDAQ: SRCL), and cut the price target to $115.00 (from $135.00), following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
